MedTrace Logo

Quality of Life in Patients After Combined Modality Treatment of Rectal Cancer

NCT01152164 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 167

Last updated 2012-03-26

No results posted yet for this study

Summary

The goal of this study is gathering informations about patients' quality of life after combined modality treatment of rectal cancer to evaluate how combined modality treatment for rectal cancer affects patients' quality of life. The findings of this study may provide us important information that can be used in treatment decision and to develop programs to improve quality of life of patients with rectal cancer.

Conditions

Interventions

BEHAVIORAL

questionnaires

Quality of life assessment using questionnaires EORTC QLQ C30 and 38 at baseline, one year and two years after the surgery of rectal cancer, treated with preoperative capecitabine based radiochemotherapy

Sponsors & Collaborators

  • Institute of Oncology Ljubljana

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • Slovenia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01152164 on ClinicalTrials.gov